Derivation Web

v0.1 · api
source · text/csv

source_036790f6b5c14f28

sha256 9c61516cf6fc4c3ed68c7ccaee64b96bc3ffeb5720d534af28f5782f4c689ff0

by researka:v2 · 2026-08-01 01:01:45.886191+04:00

study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness
Efficacy comparison of dapagliflozin combined with liraglutide versus monotherapy in obese patients with heart failure,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,indirect
Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss,not extracted,not extracted,not extracted,not extracted,not extracted,some_concerns,direct
"Effect of Liraglutide on Arterial Inflammation Assessed as [ 18 F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial",not extracted,not extracted,not extracted,not extracted,not extracted,some_concerns,direct
Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review
Assessment of cardiovascular event reduction with SGLT2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes mellitus,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,indirect
Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study,not extracted,not extracted,not extracted,not extracted,not extracted,some_concerns,direct
Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review
Myocardial deformation links combined liraglutide–empagliflozin therapy with improved cardiovascular and economic outcomes in type 2 diabetes: a 6-year study,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,indirect
Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,indirect
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride,not extracted,not extracted,not extracted,not extracted,not extracted,some_concerns,direct
"Preventive effect of liraglutide on postoperative delirium in elderly patients undergoing cardiac surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial",not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,protocol
Real-world cardiovascular effects of liraglutide: transportability analysis of the LEADER trial,not extracted,not extracted,not extracted,not extracted,not extracted,some_concerns,direct
Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial,not extracted,not extracted,not extracted,not extracted,not extracted,some_concerns,direct
Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,indirect
Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,indirect
Cardiovascular outcomes of liraglutide in patients with type 2 diabetes,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,indirect
Liraglutide for weight management: a critical review of the evidence,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review
Liraglutide and obesity: a review of the data so far,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review
metadata
{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "ae3d602f-12d6-4ef2-acd8-d49b2bc98cbe",
  "researka_submission_id": "2db477af-8fdb-4e36-a847-efff42b8db40",
  "sidecar_name": "evidence_table.csv",
  "sidecar_url": "https://api.researka.org/publications/ae3d602f-12d6-4ef2-acd8-d49b2bc98cbe/sidecars/evidence_table.csv"
}

view full chain →